ArticleJournal of diabetes investigation2020

Effects of liraglutide and empagliflozin added to insulin therapy in patients with type 2 diabetes: A randomized controlled study.

Hirotatsu Nakaguchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.